Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Cipla
McKinsey
Boehringer Ingelheim
Federal Trade Commission
UBS
Johnson and Johnson
Colorcon
Moodys

Generated: April 23, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: levomilnacipran hydrochloride

« Back to Dashboard

levomilnacipran hydrochloride

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Allergan Sales Llc FETZIMA levomilnacipran hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 204168 NDA Allergan USA, Inc. N 0456-2202-28
Allergan Sales Llc FETZIMA levomilnacipran hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 204168 NDA Allergan USA, Inc. N 0456-2212-90
Allergan Sales Llc FETZIMA levomilnacipran hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 204168 NDA Allergan USA, Inc. N 0456-2212-30
Allergan Sales Llc FETZIMA levomilnacipran hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 204168 NDA Allergan USA, Inc. N 0456-2220-30
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cipla
Baxter
Harvard Business School
Johnson and Johnson
Cantor Fitzgerald
Deloitte
Fish and Richardson
QuintilesIMS